Citations

Showing 10 of 108083 citations.

Prognostic Value of Month 1 Bone Marrow and PET MRD Status in CAR-T Therapy for Myeloma
Bansal, Radhika , Larsen, Jeremy T. , Hathcock, Matthew , Kapoor, Prashant , Kourelis, Taxiarchis , Hayman, Suzanne R. , Warsame, Rahma , Kumar, Shaji , Lin, Yi , Ailawadhi, Sikander , Gertz, Morie A. , Dingli, David , Binder, Moritz , Parrondo, Ricardo D , Fonseca, Rafaël , Bergsagel, P. Leif

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1862-1864

10.1182/blood-2022-166662 Get It

Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Biomarker-Selected Patients with Relapsed or Refractory Multiple Myeloma: Implication for Dose Selection
Badawi, Mohamed , Coppola, Sheryl , Eckert, Doerthe , Gopalakrishnan, Sathej , Doelger, Eva, Dobkowska, Edyta, Kumar, Shaji , Menon, Rajeev , Huang, Weize , Salem, Ahmed Hamed

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4281-4282

10.1182/blood-2022-166584 Get It

Comparative Effectiveness of Lenalidomide/Dexamethasone-Based Triplet Regimens for Treatment of Relapsed and/or Refractory Multiple Myeloma in Subgroups Defined By Cytogenetic Risk
Sanchez, Larysa , Cheng, Mu, Cherepanov, Dasha , DerSarkissian, Maral , Stull, Dawn Marie, Hilts, Annalise, Duh, Mei Sheng , Huang, Fei, Chun, Justin, Ailawadhi, Sikander

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4308-4309

10.1182/blood-2022-156320 Get It

Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review
Tran, Diana , Rosta, Emily, Laidlaw, Alyshia , Rai, Manvir, Duran, Joana , Ammann, Eric M. , Fonseca, Rafaël

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5212-5213

10.1182/blood-2022-165569 Get It

Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)
Seymour, John F. , Byrd, John C. , Munir, Talha, Kater, Arnon P. , Chanan‐Khan, Asher , Furman, Richard R. , O’Brien, Susan, Brown, Jennifer R. , Mato, Anthony R. , Fehn, Thomas, Miranda, Paulo Andre P. de, Higgins, Kara, John, Ellie , Borja, Marianne de, Woyach, Jennifer A. , Byrd, John C , Ghia, Paolo , O’Brien, Susan , Stilgenbauer, Stephan , Fehn, Thomas, Jurczak, Wojciech

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7050-7052

10.1182/blood-2022-157060 Get It

Understanding Patient Perspective, Challenges, Behavioral Patterns, and Preferences Towards Participation in Multiple Myeloma Clinical Trials: A Prospective Study
Hydren, Jay R., Seng, Felicia, Baksh, Mizba , Rasheed, Ahsan , Abdulazeez, Mays F , Ailawadhi, Meghna, George, Keren, Alegria, Victoria R., Advani, Pooja , Starr, Jason S. , Sher, Taimur , Ahlstrom, Jennifer M., Chanan‐Khan, Asher , Ailawadhi, Sikander , Bojanini, Leyla , Sweeney, Nathan W. , Parrondo, Ricardo D , Roy, Vivek , Manochakian, Rami

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7941-7942

10.1182/blood-2022-167005 Get It

Real World Outcomes of Brentuximab Vedotin Maintenance after Autologous Stem Cell Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma: An Time-Variable Analysis of the Effect of Dose on Progression Free Survival
Nedved, Adrienne, Micallef, Ivana N. , Hatic, Haris, Zacholski, Erin, Fegley, Amanda , Sigmund, Audrey M. , Samuels, Courtney , Aqeel, Sheeba Ba, Torka, Pallawi , MacDougall, Kira , Borogovac, Azra , Rajeeve, Sridevi , Fedak, Kalub, Modi, Dipenkumar , Travers, Elizabeth, Chilakamarri, Nitin, Brém, Elizabeth , Fitzgerald, Lindsey , Shah, Harsh , Shah, Harsh , Wagner, Charlotte B , Ermann, Daniel A. , Boucher, Kenneth , Desai, Sanjal H. , Goyal, Gaurav , Zacholski, Erin, Bond, David A. , Kamdar, Manali , Sundaram, Suchitra , Ayyappan, Sabarish Ram , Stephens, Deborah M. , Hu, Boyu

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9390-9392

10.1182/blood-2022-159001 Get It

Comparing Survival Outcomes of Autologous and Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Nodal Peripheral T-Cell Lymphoma
Eatrides, Jennifer , Lazaryan, Aleksandr , Liu, Hien , Ibarz, Javier Pinilla, Kharfan‐Dabaja, Mohamed A. , Ayala, Ernesto, Sokol, Lubomir , Zhang, Yumeng , Rose, Ashley M. , Zhang, Ling , Khimani, Farhad , Shah, Bijal , Saeed, Hayder , Jain, Michael D. , Locke, Frederick L. , Kim, Jongphil , Sokol, Lubomir , Nishihori, Taiga

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10634-10636

10.1182/blood-2022-169200 Get It